Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 261

1.

Hepatic glycerol metabolism is early reprogrammed in rat liver cancer development.

Lorenzetti F, Capiglioni AM, Marinelli RA, Carrillo MC, Alvarez ML.

Biochimie. 2020 Jan 7;170:88-93. doi: 10.1016/j.biochi.2020.01.002. [Epub ahead of print]

PMID:
31923480
2.

Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Phillips ML, Stage EC Jr, Lane KA, Gao S, Risacher SL, Goukasian N, Saykin AJ, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2020 Jan 3:1-12. doi: 10.1159/000504341. [Epub ahead of print]

PMID:
31901905
3.

Bidirectional cingulate-dependent danger information transfer across rats.

Han Y, Bruls R, Soyman E, Thomas RM, Pentaraki V, Jelinek N, Heinemans M, Bassez I, Verschooren S, Pruis I, Van Lierde T, Carrillo N, Gazzola V, Carrillo M, Keysers C.

PLoS Biol. 2019 Dec 5;17(12):e3000524. doi: 10.1371/journal.pbio.3000524. eCollection 2019 Dec.

4.

Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy.

Lorenzetti F, Vera MC, Ceballos MP, Ronco MT, Pisani GB, Monti JA, Lucci A, Comanzo CG, Tordjmann T, Carrillo MC, Quiroga AD, Alvarez ML.

Sci Rep. 2019 Dec 3;9(1):18176. doi: 10.1038/s41598-019-54652-7.

5.

Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease.

Rabinovici GD, Carrillo MC.

JAMA Intern Med. 2019 Dec 1;179(12):1736-1737. doi: 10.1001/jamainternmed.2019.5114. No abstract available.

PMID:
31790526
6.

Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers.

Gupta Y, Lama RK, Kwon GR; Alzheimer's Disease Neuroimaging Initiative.

Front Comput Neurosci. 2019 Oct 16;13:72. doi: 10.3389/fncom.2019.00072. eCollection 2019.

7.

Multimodal Hippocampal Subfield Grading For Alzheimer's Disease Classification.

Hett K, Ta VT, Catheline G, Tourdias T, Manjón JV, Coupé P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Sep 25;9(1):13845. doi: 10.1038/s41598-019-49970-9.

8.

New Perspective for Non-invasive Brain Stimulation Site Selection in Mild Cognitive Impairment: Based on Meta- and Functional Connectivity Analyses.

Liu J, Zhang B, Wilson G, Kong J; Alzheimer’s Disease Neuroimaging Initiative.

Front Aging Neurosci. 2019 Aug 27;11:228. doi: 10.3389/fnagi.2019.00228. eCollection 2019.

9.

The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory.

Li Y, Yao Z, Yu Y, Fu Y, Zou Y, Hu B; Alzheimer’s Disease Neuroimaging Initiative.

Front Aging Neurosci. 2019 Aug 8;11:208. doi: 10.3389/fnagi.2019.00208. eCollection 2019.

10.

Performing Sparse Regularization and Dimension Reduction Simultaneously in Multimodal Data Fusion.

Yang Z, Zhuang X, Bird C, Sreenivasan K, Mishra V, Banks S, Cordes D; Alzheimer's Disease Neuroimaging Initiative.

Front Neurosci. 2019 Jul 3;13:642. doi: 10.3389/fnins.2019.00642. eCollection 2019.

11.

IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.

Quiroga AD, Comanzo CG, Heit Barbini FJ, Lucci A, Vera MC, Lorenzetti F, Ferretti AC, Ceballos MP, Alvarez ML, Carrillo MC.

Toxicol Appl Pharmacol. 2019 Sep 15;379:114650. doi: 10.1016/j.taap.2019.114650. Epub 2019 Jul 9.

PMID:
31299271
12.

Emotional Mirror Neurons in the Rat's Anterior Cingulate Cortex.

Carrillo M, Han Y, Migliorati F, Liu M, Gazzola V, Keysers C.

Curr Biol. 2019 Jun 17;29(12):2104. doi: 10.1016/j.cub.2019.05.064. No abstract available.

13.

Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.

Zhao Q, Liu M, Ha L, Zhou Y; Alzheimer's Disease Neuroimaging Initiative.

Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019.

14.

Emotional Mirror Neurons in the Rat's Anterior Cingulate Cortex.

Carrillo M, Han Y, Migliorati F, Liu M, Gazzola V, Keysers C.

Curr Biol. 2019 Apr 22;29(8):1301-1312.e6. doi: 10.1016/j.cub.2019.03.024. Epub 2019 Apr 11. Erratum in: Curr Biol. 2019 Jun 17;29(12):2104.

15.

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.

Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, Romanoff J, Siegel BA, Whitmer RA, Carrillo MC.

JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000.

16.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.

Varatharajah Y, Ramanan VK, Iyer R, Vemuri P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 19;9(1):2235. doi: 10.1038/s41598-019-38793-3.

17.

Predicting Alzheimer's disease progression using multi-modal deep learning approach.

Lee G, Nho K, Kang B, Sohn KA, Kim D; for Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 13;9(1):1952. doi: 10.1038/s41598-018-37769-z.

18.

Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats.

Vera MC, Lorenzetti F, Lucci A, Comanzo CG, Ceballos MP, Pisani GB, Alvarez ML, Quiroga AD, Carrillo MC.

Nutrition. 2019 Mar;59:170-179. doi: 10.1016/j.nut.2018.08.016. Epub 2018 Aug 25.

PMID:
30496957
19.

Military-related risk factors for dementia.

Snyder HM, Carare RO, DeKosky ST, de Leon MJ, Dykxhoorn D, Gan L, Gardner R, Hinds SR 2nd, Jaffee M, Lamb BT, Landau S, Manley G, McKee A, Perl D, Schneider JA, Weiner M, Wellington C, Yaffe K, Bain L, Pacifico AM, Carrillo MC.

Alzheimers Dement. 2018 Dec;14(12):1651-1662. doi: 10.1016/j.jalz.2018.08.011. Epub 2018 Nov 8. Review.

20.

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.

Shaw LM, Arias J, Blennow K, Galasko D, Molinuevo JL, Salloway S, Schindler S, Carrillo MC, Hendrix JA, Ross A, Illes J, Ramus C, Fifer S.

Alzheimers Dement. 2018 Nov;14(11):1505-1521. doi: 10.1016/j.jalz.2018.07.220. Epub 2018 Oct 10.

Supplemental Content

Loading ...
Support Center